Original paper
Clinical significance of immune-related creatine phosphokinase increase associated with anti PD1/PD-L1 immunotherapies
Abstract
Background null Anti-PD1 and anti-PD-L1 are effective checkpoints inhibitors to stimulate the immune system against many types of cancers. The flip side of these immunotherapies is the generation of immune-related adverse events (irAE), which can theoretically affect all organs including muscle tissue. Immune-related creatine phosphokinase (irCPK) increase is associated with immune related myositis. The meaning of CPK monitoring in clinical...
Paper Details
Title
Clinical significance of immune-related creatine phosphokinase increase associated with anti PD1/PD-L1 immunotherapies
Published Date
Oct 1, 2019
Journal
Volume
30
Pages
v526 - v526
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History